“Improving ancillary shielding barriers is paramount,” according to the authors of a brand new analysis. 

The deal brings Integra’s more than 40,000 Medicaid members and network of care management teams to Anthem, which serves more than 118 million people.

As a result, the company stated it will pause the practice of prescribing controlled substances as a treatment for ADHD such as Adderall and Ritalin for new patients starting May 9.

Hello Heart, a digital therapeutics company that focuses on heart health, has raised $70 million in a Series D funding round.

The trial is expected to enroll up to 650 patients from as many as 100 different facilities throughout the world.

The interventional radiology practice of an academic medical center has identified four challenges to securing informed consent from patients or their medical decision-makers. 

In pediatric care settings, hybrid PET/MR imaging combines “exquisite soft-tissue information obtained by MR imaging with functional information provided by PET.”

With the shortage, which pertains specifically to all formulations and concentrations of GE Healthcare’s Omnipaque (iohexol), expected to last until mid-June, several organizations have alluded that conservation efforts are of critical importance.

Engineers detailed their prototype, which is roughly the size of a small stack of quarters, in Nature Biomedical Engineering.

The study's authors tracked data from six different randomized controlled trials, including a large study from 2021 that focused on myocardial infarction patients.